Patents by Inventor Michaela Shottes

Michaela Shottes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11781126
    Abstract: Proteases are enzymes which hydrolyze protein enzymes, eliminating their activity. The present invention exploits the hydrolyzing activity of proteases including proteinase K, endoproteinase LysC and/or trypsin to control the activity of restriction enzymes and/or eliminate or reduce production of unwanted DNA or RNA fragments (known as star activity).
    Type: Grant
    Filed: November 12, 2022
    Date of Patent: October 10, 2023
    Assignee: ABclonal Science, Inc.
    Inventors: Zhenyu Zhu, Dapeng Sun, Aine Quimby, Michaela Shottes
  • Patent number: 11767524
    Abstract: Disclosed is a product and process, wherein one adds a N-terminal Histamine-Maltose Binding Protein (“MBP”) tag to endonucleases, including restriction endonucleases like Hind III, and binds the tagged fusion protein to a solid support, preferably beads, once the enzyme has digested oligonucleotides in solution, in order to arrest further digestion. Preferred beads for binding the tagged enzyme are magnetic beads, which can easily be removed from solution by binding to a support and then removing it, or can be accumulated by magnetic attraction in a particular region. More preferred are magnetic beads bound to iminodiacetic acid or nitrilotriacetic acid.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: September 26, 2023
    Assignee: ABclonal Science, Inc.
    Inventors: Zhenyu Zhu, Dapeng Sun, Michaela Shottes
  • Patent number: 11512296
    Abstract: Proteases are enzymes which hydrolyze protein enzymes, eliminating their activity. The present invention exploits the hydrolyzing activity of proteases including proteinase K, endoproteinase LysC and/or trypsin to control the activity of restriction enzymes and/or eliminate or reduce production of unwanted DNA or RNA fragments (known as star activity).
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: November 29, 2022
    Assignee: ABclonal Science, Inc.
    Inventors: Zhenyu Zhu, Dapeng Sun, Aine Quimby, Michaela Shottes
  • Publication number: 20210171925
    Abstract: Proteases are enzymes which hydrolyze protein enzymes, eliminating their activity. The present invention exploits the hydrolyzing activity of proteases including proteinase K, endoproteinase LysC and/or trypsin to control the activity of restriction enzymes and/or eliminate or reduce production of unwanted DNA or RNA fragments (known as star activity).
    Type: Application
    Filed: February 9, 2021
    Publication date: June 10, 2021
    Inventors: Zhenyu Zhu, Dapeng Sun, Aine Quimby, Michaela Shottes
  • Publication number: 20210087550
    Abstract: Disclosed is a product and process, wherein one adds a N-terminal Histamine-Maltose Binding Protein (“MBP”) tag to endonucleases, including restriction endonucleases like Hind III, and binds the tagged fusion protein to a solid support, preferably beads, once the enzyme has digested oligonucleotides in solution, in order to arrest further digestion. Preferred beads for binding the tagged enzyme are magnetic beads, which can easily be removed from solution by binding to a support and then removing it, or can be accumulated by magnetic attraction in a particular region. More preferred are magnetic beads bound to iminodiacetic acid or nitrilotriacetic acid.
    Type: Application
    Filed: September 22, 2020
    Publication date: March 25, 2021
    Inventors: Zhenyu Zhu, Dapeng Sun, Michaela Shottes
  • Patent number: 10947518
    Abstract: Proteases are enzymes which hydrolyze protein enzymes, eliminating their activity. The present invention exploits the hydrolyzing activity of proteases including proteinase K, endoproteinase LysC and/or trypsin to control the activity of restriction enzymes and/or eliminate or reduce production of unwanted DNA or RNA fragments (known as star activity).
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: March 16, 2021
    Assignee: ABclonal Science, Inc.
    Inventors: Zhenyu Zhu, Dapeng Sun, Aine Quimby, Michaela Shottes
  • Patent number: 10920202
    Abstract: Disclosed is an engineered thermolabile mutant of Serratia Marcescens Nuclease. In the same buffer as used for optimal enzyme activity, after 60° C. for 20 min, while the wild type retained 12.5% activity, the thermolabile mutant R146D/D156R/D229R/D245R (SEQ ID NO: 12, without the first 21 amino acids, which are a signal peptide) retained only 0.39% activity. Heat inactivation of the mutant, when it is used for protein purification, can be used after a period when substantial DNA in a protein has been degraded, but before unwanted degradation takes place.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: February 16, 2021
    Assignee: AbClonal Science, Inc.
    Inventors: Zhenyu Zhu, Dapeng Sun, Michaela Shottes